THE AUTHORS RESPOND.
Saved in:
| Title: | THE AUTHORS RESPOND. |
|---|---|
| Authors: | Xu X; BioPharmaceuticals Market Access and Pricing, AstraZeneca, Gaithersburg, MD; BioPharmaceuticals Global Medical Affairs, AstraZeneca, Gaithersburg, MD., Katial R; BioPharmaceuticals Global MedicalAffairs, AstraZeneca, Gaithersburg, MD., Schaefer C; Product Development & Market Access Consulting, Labcorp Drug Development, Gaithersburg, MD., Szende A; Product Development & Market Access Consulting, Labcorp Drug Development, Leeds, UK., Genofre E; BioPharmaceuticals US Medical Affairs, AstraZeneca, Wilmington, DE., Chung Y; BioPharmaceuticals US Medical Affairs, AstraZeneca, Wilmington, DE. |
| Source: | Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Apr; Vol. 30 (4), pp. 398-399. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
